Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report
JMIR Dermatology · 29.06.2026 · 9 · e86892-e86892
DOI: 10.2196/86892 ↗Kurz gefasst
Fallbericht in der Zeitschrift JMIR Dermatology, online erschienen am 29.06.2026. Verfasst von Thien-Chong Marcus Wong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wong's Plastic Surgery Centre, Gleneagles Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Collagen, Rhytidoplasty. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Fractional radio frequency microneedling (FRM) is an effective nonsurgical facelift modality supported by growing clinical evidence. While generally well tolerated, postprocedural erythema, pain, swelling, and bruising typically last up to 7 days. Other serious complications include prolonged swelling, infection, persistent grid mark, burns, and hypo- or hyperpigmentation. Recombinant human collagen has demonstrated potent wound-healing and anti-inflammatory properties, which could be harnessed for post-FRM recovery.
Objective
To date, there is a lack of published studies evaluating the use of topical agents to improve postprocedural recovery following FRM. This case report describes the early experience of using topical recombinant collagen post FRM for nonsurgical facelift.
Methods
Two 40-year-old female patients with Fitzpatrick skin type IV underwent FRM for nonsurgical facelift. The procedure was performed with standard energy settings. Immediately post procedure, topical recombinant collagen was applied to the treated areas. Either clinical photography or cross-polarized imaging was used to objectively capture the changes in facial erythema and swelling.
Results
Both cases demonstrated a marked reduction of erythema and inflammation within 1 to 2 hours after application of topical recombinant collagen. These observations appeared earlier compared to the typical timeframe of 1 to 3 days. No adverse events were reported.
Conclusions
Topical recombinant collagen application post FRM was associated with an early reduction of skin erythema and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wong's Plastic Surgery Centre, Gleneagles Hospital, Singapore, Singapore.
- Department for Continuing Education, University of Oxford, Rewley House, 1 Wellington Square, Oxford, OX1 2IA, United Kingdom, +44 7428612914.
ORCID-Profile: Thien-Chong Marcus Wong, Yizhi Ong
Zitieren
APA
Wong, T. M., & Ong, Y. (2026). Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report. JMIR Dermatology, 9, e86892-e86892. https://doi.org/10.2196/86892
Vancouver
Wong TM, Ong Y. Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report. JMIR Dermatology. 2026;9:e86892-e86892. doi:10.2196/86892
BibTeX
@article{Wong2026,
author = {Wong, Thien-Chong Marcus and Ong, Yizhi},
title = {Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report},
journal = {JMIR Dermatology},
year = {2026},
volume = {9},
pages = {e86892--e86892},
doi = {10.2196/86892}
}
EUVIMED